# FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis

> **NCT04636268** · PHASE3 · WITHDRAWN · sponsor: **Instituto Grifols, S.A.**

## Conditions studied

- Congenital Afibrinogenemia
- Hypofibrinogenemia

## Interventions

- **BIOLOGICAL:** FIB Grifols

## Key facts

- **NCT ID:** NCT04636268
- **Lead sponsor:** Instituto Grifols, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-12
- **Primary completion:** 2025-03
- **Final completion:** 2025-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was stopped due to a business decision.
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04636268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04636268, "FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04636268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*